Atlas Trials

Trans-RosaLEE Study: a Biomarker-directed, Translational Study

Clinical trial NCT05529862 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05529862
Sponsor
Institut Paoli-Calmettes
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Advanced or Metastatic Breast Cancer (BC)
Start date
2023-06-20
Primary completion
2028-11-01
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.